Instructions for Orcepol VM (Ciprofloxacin, Ornidazole) 10 pills
English product name
Description Orcepol VM:
The tablets are covered with a light yellow film shell, oval, double-convex, with "ORCP" etched on one side and a dividing line on the other.
Ciprofloxacin hydrochloride 554.92 mg,
which corresponds to Ciprofloxacin content 500 mg
ornidazol 500 mg
Auxiliary substances: sodium carboxymethyl starch - 141.44 mg, sodium croscarmellose - 50 mg, povidon K29/32 - 17.4 mg, magnesium stearate - 7.8 mg, silicon dioxide colloidal - 16.6 mg, talc - 9.3 mg, cornstarch - up to 1420 mg.
Film sheath composition: opadray II yellow 02F22025 - 42 mg (hypromellose - 26.25 mg, titanium dioxide - 11.23 mg, macrogol - 2.625 mg, iron oxide yellow - 1.47 mg, talc - 0.42 mg).
10 pcs - blister packs (1) - cardboard packs.
10 pcs - blister packs (2) - cardboard packs.
J01RA Antibacterial Drug Combinations
Clinical-pharmacological groups / Group affiliation
Combined preparation having an antibacterial and antiplatelet effect
Pharmacotherapy group Orcepol VM:
Antimicrobial combined agent
The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.
Best before date
Shelf life is 3 years. Do not apply after expiry date.
mixed bacterial infections caused by sensitive gram-positive and gram-negative microorganisms, in combination with anaerobic microorganisms and/or protozoa: Infection and inflammatory diseases of the abdominal organs and the biliary tract, kidneys (pyelonephritis) and/or complicated infections of the urinary tract, genitals and pelvic organs (adnexitis, prostatitis, epididymium).
Official national recommendations for the appropriate use of antibacterial agents, as well as the sensitivity of pathogenic microorganisms in a particular region, should be taken into account when using Orcepol VM.
Method of use, course and dosage Ornidazole:
The drug is taken in 1 hour before eating or 2 hours after eating, not chewing, drinking enough water.
The recommended dose is 1 tabb. 2 times / day.
The course of treatment for acute infections is 5-7 days, in case of treatment of chronic infections the course is 10-14 days.
It is necessary to continue taking the drug for 2 days after the removal of symptoms of the disease.
Application in elderly patients
With care, the drug should be used in patients of old age.
Use in children
Use under 18 years of age is contraindicated.
Nosology (ICD codes)
Acute peritonitis (including abscess)
Acute tubuloinsterstitial nephritis (acute pielonephritis)
Chronic tubulointerstitial nephritis (chronic pyelonephritis)
Urethritis and urethral syndrome
Inflammatory prostate diseases
Orchite and Epidimite
Salpingitis and oophorite
Inflammatory disease of the uterus, except the cervix (including endometritis, myometritis, metritol, pyometra, abscess of the uterus)
Inflammatory disease of the cervix (incl. cervicite, endocervicite, exocervicite)
Pharmacological effect Ornidazole:
A combined antimicrobial and antiviral preparation, the pharmacological effect of which is determined by the properties of the active ingredients contained therein: ornithazole (5-nitroimidazole derivative) and Ciprofloxacin (II generation fluoroquinolone derivative).
Ornithazole, an antimicrobial and antiprotozoan agent, is effective against Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia (Giardia integrinalis), as well as some anaerobic bacteria such as Bacteroides spp., Clostridium spp., Fusohacterium spp., and anaerobic cocci: Peptostreptococcus spp., Peptococcus spp.
Ciprofloxacin is a broad-spectrum synthetic antibacterial drug from the fluoroquinolone group. It has in vitro activity against a wide range of gram-negative and gram-positive microorganisms. The bactericidal action of Ciprofloxacin is by inhibiting bacterial topoisomerase type II (topoisomerase II (DNA-gyraz) and topoisomerase IV), which are essential for the replication, transcription, repair and recombination of bacterial DNA.